References

2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases.

10.1002/art.42386 · 2023 · External reference

A guide to vaccinology: from basic principles to new developments.

10.1038/s41577-020-00479-7 · 2021 · External reference

Joint-specific memory, resident memory T cells and the rolling window of opportunity in arthritis.

10.1038/s41584-024-01107-7 · 2024 · External reference

Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.

10.1136/annrheumdis-2018-213222 · 2018 · External reference

Temporary cessation of DMARD therapy and COVID-19 supplemental dose vaccine immunogenicity in patients with inflammatory arthritis: the COVER randomized clinical trial.

External reference

Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial.

10.1016/j.ard.2026.01.002 · 2026 · External reference

American College of Rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5.

10.1002/art.42372 · 2023 · External reference

Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial.

10.1016/s2665-9913(24)00084-5 · 2024 · External reference